KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Share-based Compensation (2016 - 2025)

LifeMD's Share-based Compensation history spans 14 years, with the latest figure at $2.7 million for Q3 2025.

  • For Q3 2025, Share-based Compensation rose 28.57% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $5.2 million, down 32.7%, while the annual FY2025 figure was $535000.0, 95.63% down from the prior year.
  • Share-based Compensation reached $2.7 million in Q3 2025 per LFMD's latest filing, up from $2.5 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $4.5 million in Q1 2022 to a low of $6000.0 in Q2 2023.
  • Average Share-based Compensation over 5 years is $2.6 million, with a median of $2.7 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: soared 2325.21% in 2021, then plummeted 99.85% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $4.1 million in 2021, then plummeted by 53.9% to $1.9 million in 2022, then skyrocketed by 93.44% to $3.6 million in 2023, then dropped by 14.83% to $3.1 million in 2024, then fell by 13.04% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Share-based Compensation are $2.7 million (Q3 2025), $2.5 million (Q1 2025), and $3.1 million (Q4 2024).